Sign in

American Healthcare REIT, Inc. AHR

Price 56.2 USD
as of 2026-09-03
44/100
Weak
Quality33
Growth80
Balance-sheet strength36
Valuation23
Momentum65
Income50

Composite 44/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Valuation ranks 23/100 — a strong mark against it.

Case for

Growth ranks 80/100 — a strong point in its favour. Momentum ranks 65/100 — a moderate point in its favour.

Case against

Valuation ranks 23/100 — a strong mark against it. Quality ranks 33/100 — a moderate mark against it. Balance-sheet strength ranks 36/100 — a moderate mark against it.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.